{"id":91690,"date":"2022-11-18T00:00:00","date_gmt":"2022-11-18T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2022\/11\/18\/stable-neurodevelopment-seen-for-most-children-with-familial-high-risk-for-schizophrenia\/"},"modified":"2022-11-22T01:18:43","modified_gmt":"2022-11-22T01:18:43","slug":"stable-neurodevelopment-seen-for-most-children-with-familial-high-risk-for-schizophrenia","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2022\/11\/18\/stable-neurodevelopment-seen-for-most-children-with-familial-high-risk-for-schizophrenia\/","title":{"rendered":"Stable Neurodevelopment Seen for Most Children With Familial High Risk for Schizophrenia"},"content":{"rendered":"<h3>\n<p>12.8 percent of children with familial high risk for schizophrenia, bipolar disorder transition to different neurocognitive subgroup<\/p>\n<\/h3>\n<p><b>By Elana Gotkine HealthDay Reporter<\/b><\/p>\n<p><b><\/b><\/p>\n<p>FRIDAY, Nov. 18, 2022 (HealthDay News) &#8212; Most children at familial high risk for schizophrenia (FHR-SZ) or bipolar disorder (FHR-BP) have stable neurocognitive development, but some transition to a different, usually more impaired, subgroup, according to a study published online Oct. 6 in <em>Schizophrenia Bulletin<\/em>.<\/p>\n<p>Christina Bruun Knudsen, from Aarhus University Hospital-Psychiatry in Denmark, and colleagues examined transitions between neurocognitive subgroups among children at FHR-SZ or FHR-BP from age 7 to 11 years in a latent profile analysis that was used to identify subgroups at two assessments based on performance of 320 children across eight neurocognitive functions. Temporal stability in subgroup membership was examined. A reference group of population-based controls was included (199 at age 7 years; 178 at age 11 years).<\/p>\n<p>The researchers identified three subgroups based on neurocognitive performance at both time points: moderately-to-severely impaired, mildly impaired, and above-average subgroups. Overall, 12.8 percent of children transitioned to a different subgroup; 85.2 percent transitioned to a more impaired subgroup. Children transitioning to a more impaired subgroup were differentiated from nontransitioning children by a parental diagnosis of schizophrenia, but not by parental diagnosis of bipolar disorder, global functioning at age 7 years, psychopathology, or sex.<\/p>\n<p>&#8220;Most children remained in their subgroup at follow-up, showing stable neurocognitive development from age 7 to 11,&#8221; the authors write. &#8220;However, a substantial minority of children changed subgroup membership, of which almost all transitions were to a more impaired subgroup, indicating developmental lags.&#8221;<\/p>\n<p><a href=\"https:\/\/academic.oup.com\/schizophreniabulletin\/advance-article-abstract\/doi\/10.1093\/schbul\/sbac134\/6749564?redirectedFrom=fulltext\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2022 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>12.8 percent of children with familial high risk for schizophrenia, bipolar disorder transition to different neurocognitive subgroup<\/p>\n","protected":false},"author":6,"featured_media":91782,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-91690","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/91690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=91690"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/91690\/revisions"}],"predecessor-version":[{"id":91781,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/91690\/revisions\/91781"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/91782"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=91690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=91690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=91690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}